KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $194.6 million.

  • Charles River Laboratories International's Cash & Equivalents fell 1.46% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.1 million, marking a year-over-year decrease of 1.46%. This contributed to the annual value of $194.6 million for FY2024, which is 29.69% down from last year.
  • Per Charles River Laboratories International's latest filing, its Cash & Equivalents stood at $194.6 million for FY2024, which was down 29.69% from $276.8 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Cash & Equivalents peaked at $276.8 million during FY2023, and registered a low of $194.6 million during FY2024.
  • For the 3-year period, Charles River Laboratories International's Cash & Equivalents averaged around $235.1 million, with its median value being $233.9 million (2022).
  • Per our database at Business Quant, Charles River Laboratories International's Cash & Equivalents grew by 18.32% in 2023 and then dropped by 29.69% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Cash & Equivalents (Yearly) stood at $228.4 million in 2020, then rose by 5.60% to $241.2 million in 2021, then dropped by 3.03% to $233.9 million in 2022, then climbed by 18.32% to $276.8 million in 2023, then declined by 29.69% to $194.6 million in 2024.